Similar results to the cell line studies were seen when treating breast cancer-derived PDXO with the same combinations, supporting the idea that GDF15 neutralization in combination with drug treatment may hold considerable potential as an effective therapeutic approach for breast cancer. The gene discussed is GDF15; the disease is breast carcinoma.